Back

Single-cell transcriptomics, scRNA-Seq and C1 CAGE discovered distinct phases of pluripotency during naïve-to-primed conversion in mice

Böttcher, M.; Tada, Y.; Moody, J.; Kondo, M.; Ura, H.; Abugessaisa, I.; Kasukawa, T.; Hon, C.-C.; Nagao, K.; Carninci, P.; Abe, K.

2020-09-25 genomics
10.1101/2020.09.25.313239 bioRxiv
Show abstract

BackgroundTwo types of mammalian pluripotent stem cells (PSC), i.e. naive and primed possess distinct cellular characteristics. It is largely unknown how these differences are generated during naive-to-primed transition process. We have established a robust in vitro transition system using a Wnt inhibitor for the first time and analyzed dynamic changes in cellular status via single-cell RNA-sequencing and C1 CAGE analyses. ResultsAnalysis of known marker genes suggested that the cell transition process progresses as expected. However, cluster analyses revealed a sudden increase in expression profile diversities three and four days after induction of the transition. These expression diversities can be reconciled by the presence of two subpopulations with distinct transcription profiles emerging at these time points. One of the subpopulations appears transiently, and surprisingly these cells showed a global downregulation of gene expression. Moreover, initiation of random X chromosome inactivation (XCI) coincides with the appearance of these transient cells. The other subpopulation can be maintained as a stem cell line and possesses expression profiles more similar to those of primed epiblast stem cells (EpiSC) than embryonic stem cells (ESC). However, there are important differences in gene expression related to epithelial-mesenchymal transition (EMT), suggesting that this subpopulation may represent a novel pluripotent state that has an intermediate cellular phenotype between ESC and EpiSC. ConclusionsThese findings should contribute to our understanding of the establishment and maintenance of distinct differentiation statuses of mammalian PSCs and provide new insights into the pluripotency spectrum in general.

Matching journals

The top 8 journals account for 50% of the predicted probability mass.

1
Stem Cell Research & Therapy
30 papers in training set
Top 0.1%
14.2%
2
Scientific Reports
3102 papers in training set
Top 12%
7.1%
3
Stem Cell Reports
118 papers in training set
Top 0.1%
6.3%
4
Stem Cell Research
16 papers in training set
Top 0.1%
6.3%
5
PLOS ONE
4510 papers in training set
Top 29%
6.3%
6
Genes
126 papers in training set
Top 0.1%
4.8%
7
Frontiers in Genetics
197 papers in training set
Top 1%
4.3%
8
BMC Genomics
328 papers in training set
Top 0.9%
3.6%
50% of probability mass above
9
Computational and Structural Biotechnology Journal
216 papers in training set
Top 2%
3.6%
10
Frontiers in Cell and Developmental Biology
218 papers in training set
Top 2%
3.2%
11
Computational Biology and Chemistry
23 papers in training set
Top 0.1%
3.0%
12
Epigenetics
43 papers in training set
Top 0.3%
2.3%
13
BMC Biology
248 papers in training set
Top 0.9%
1.9%
14
Biology Open
130 papers in training set
Top 1%
1.6%
15
Journal of Clinical Medicine
91 papers in training set
Top 4%
1.6%
16
Cells
232 papers in training set
Top 3%
1.5%
17
Stem Cells
28 papers in training set
Top 0.3%
1.3%
18
Cell Death Discovery
51 papers in training set
Top 0.8%
1.3%
19
iScience
1063 papers in training set
Top 20%
1.3%
20
Molecular Biology Reports
19 papers in training set
Top 0.3%
1.2%
21
Advanced Biology
29 papers in training set
Top 1%
0.8%
22
Epigenomics
10 papers in training set
Top 0.1%
0.7%
23
Journal of Personalized Medicine
28 papers in training set
Top 1%
0.7%
24
Experimental Hematology
11 papers in training set
Top 0.3%
0.7%
25
Genomics
60 papers in training set
Top 3%
0.7%
26
PLOS Genetics
756 papers in training set
Top 16%
0.7%
27
Biology Methods and Protocols
53 papers in training set
Top 3%
0.7%
28
Biochemistry and Biophysics Reports
28 papers in training set
Top 2%
0.7%
29
Molecular Omics
21 papers in training set
Top 0.5%
0.6%
30
Differentiation
11 papers in training set
Top 0.3%
0.6%